Thank you, Madam Chair.
Thank you to our witnesses for coming today.
Dr. Carleton, in light of the evidence we have heard, I had the impression that considerable information was available on the adverse effects of drugs. What I hear you saying is that in the end, very little is received. You said that only 5% of results were published or made available. Why?
My second question is a bit of a follow-up on the previous one. You also told us that the 5% of available data often contained incomplete information. Was it incomplete due to the type of study you were doing on the human genome or was it incomplete because of the comparisons that could be made?